Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001264124-11-000003)

Filing Details

Accession Number:: 0001264124-11-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-15 17:30:35
Reporting Period:: 2011-01-18

Filing Date:: 2011-02-15
Accepted Time:: 2011-02-15 17:30:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1220966	Iii R James Gavin	9360 Towne Centre Dr San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-18	2,251	$14.94	2,251	No	4	X	Direct
Common Stock	Disposition	2011-01-18	671	$14.94	1,580	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock-Deferred Compensation	Disposition	2011-01-18	2,251	$14.94	2,251	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,536			No	4	X	Direct

Footnotes

Represents a previously elected in-service withdrawal from Amylin's Deferred Compensation Plan.
Sale of common shares to satisfy reporting person's income tax withholding obligations.
The shares of phantom stock will be distributed to the reporting person in the form of Amylin common stock in a lump sum six months following the date on which the reporting person no longer serves on Amylin's Board of Directors.